immunostimulating peptide vaccine (OPAL Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameimmunostimulating peptide vaccine (OPAL Therapeutics)
Drug Alias Nameimmunostimulating short peptide therapy (OPAL Therapeutics)immunostimulating short peptide therapy (University of Melbourne)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis CHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Melbourne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpal TherapeuticsUniversity Of Melbourne
Active IndicationsN/A
Inactive IndicationsHepatitis CHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A